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The cellular prion protein (PrPC) is a ubiquitously expressed 
membrane-anchored protein encoded by the Prnp gene. 
Misfolding of PrPC generates the scrapie prion protein (PrPSc) 
and leads to a class of invariably lethal, neurodegenerative 
conditions termed transmissible spongiform encephalopa-
thies, or prion diseases. Despite intense investigation and the 
availability of at least seven independently generated lines of 
Prnp−/− mice, little is known about the physiological function 
of PrPC (Aguzzi et al., 2013).
Two key genetic features of existing Prnp−/− mouse 
lines constitute systematic experimental confounders that 
hampered the elucidation of the physiological role of PrPC 
(Steele et al., 2007). The first confounder stems from the 
design of Prnp targeting vectors. In four lines (PrnpNgsk/Ngsk, 
PrnpRcm0/Rcm0, PrnpRkn/Rkn, and PrnpZH2/ZH2) deletion of 
Prnp exon 3 spanning a splice acceptor site resulted in spu-
rious overexpression of the Prnd-encoded Doppel protein, 
causing severe ataxia and Purkinje cell loss (Steele et al., 
2007). The second confounder depends on the embryonic 
stem (ES) cells and breeding schemes used for the generation 
of Prnp−/− mice. All Prnp−/− lines currently available have 
been generated in ES cells derived from the 129 strain of 
the laboratory mouse and are maintained in non-129 back-
grounds, with the exception of the PrnpEdbg/Edbg line. Conse-
quently, 129-derived genomic material flanking the targeted 
Prnp locus on chromosome 2 represents a systematic genetic 
confounder when Prnp−/− and PrnpWT/WT mice are com-
pared (Nuvolone et al., 2013; Striebel et al., 2013). In this 
study, we set out to overcome these limitations by generating 
a co-isogenic line of Prnp−/− mice in the well-characterized 
C57BL/6J background using transcription activator-like ef-
fector nuclease (TAL EN)–based genome editing.
RES ULTS AND DIS CUS SION
TAL EN-induced disruption of the Prnp 
protein-coding sequence
The complete protein-coding DNA sequence (CDS) for 
mouse PrPC is located within exon 3 of the Prnp gene. To 
eliminate PrPC expression in C57BL/6J without disrupting 
the Prnp gene architecture, we used a TAL EN pair targeting 
a site within the Prnp CDS in close proximity to the start 
codon (Fig. 1 A). 1 of 44 F0 pups was found to carry a Prnp 
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allele with an 8-bp deletion (termed PrnpZH3). The frame 
shift within PrnpZH3 introduced a premature stop codon in 
the sequence coding for the PrPC secretory signal peptide 
(Fig.  1 B). PrnpZH3 was efficiently transmitted through the 
germ line, and mice homozygous for PrnpZH3 were ob-
tained in the F2 generation (C57BL/6J-PrnpZH3/ZH3, hereaf-
ter termed PrnpZH3/ZH3), as assessed by restriction fragment 
length polymorphism (RFLP) analysis and TaqMan-based 
allelic discrimination assay (Fig. 1, C and D).
As expected, PrnpZH3/ZH3 mice showed no detectable 
PrPC expression in central nervous system (CNS) tissues, as 
assessed by Western blotting (Fig.  1  E), by a high sensitiv-
ity sandwich ELI SA (Fig.  1  F) or by immunofluorescence 
(Fig.  1 G). Collectively, these data indicate that a TAL EN- 
induced deletion of 8 bp within Prnp results in a functional 
disruption of the Prnp CDS and abolishes the compe-
tence for PrPC expression.
Analysis of TAL EN off-target cleavage and 
chromosomal aberrations
TAL ENs do not typically cause extensive genomic off-target 
modifications. However, cleavage of closely related off-target 
sites (OTs) can occur (Doyle et al., 2012). We PCR amplified 
eight potential OTs from the TAL EN-targeted founder and a 
C57BL/6J control (Tables S1 and S2). Amplicons were sub-
jected to an annealing protocol that enables the formation of 
heteroduplexes in the presence of heterozygous mutations. 
Treatment of these reannealed amplicons with T7 endonucle-
ase I, which cleaves heteroduplexes, did not yield any digestion 
products indicative of TAL EN off-target cleavage (Fig. 2).
We next investigated the presence of chromosomal ab-
normalities in the PrnpZH3/ZH3 line. Giemsa banding (G-band-
ing) and spectral karyotyping showed a normal 40X,Y 
karyotype (Fig. S1 A) in 14/25 metaphases from a fibroblast 
cell line obtained from a PrnpZH3/ZH3 mouse. The remaining 
karyotyped metaphases showed some degrees of chromo-
somal aberrations, including six metaphases with 79 or 80 
chromosomes, possibly representing cell culture artifacts (Lit-
tlefield and Mailhes, 1975). To account for this possibility, we 
performed G-banding analysis of primary splenocytes from 
another PrnpZH3/ZH3 mouse. Here, we found a normal 40X,Y 
karyotype in 35/35 metaphases. These analyses excluded the 
presence of large TAL EN-induced chromosomal aberrations.
We then performed high-density array comparative 
genomic hybridization (aCGH). This analysis showed the 
presence of a relative loss of genomic DNA (gDNA) in one 
PrnpZH3/ZH3 mouse compared with one C57BL/6J control 
mouse in a 34.4-kbp region of chromosome 16 encompass-
ing the Maats1 locus (Fig. S1 B). This could reflect either a 
genomic loss in the PrnpZH3/ZH3 mouse or a genomic gain 
in the C57BL/6J mouse. Copy number variants (CNVs) are 
frequently observed among different individuals of the same 
inbred colony of laboratory mice, including C57BL/6J, and 
de novo CNV occur with an incidence of 1–14% (Egan et 
al., 2007; Flatscher-Bader et al., 2011). Therefore the degree of 
Figure 1. TAL EN-based generation of C57BL/6J-PrnpZH3/ZH3 mice. 
(A) TAL EN-binding sites within Prnp exon E3 and start codon (yellow) of 
the protein coding sequence. Colors indicate the code for repeat-variable 
diresidues. The Prnp TAL EN pair incorporates second-generation heterod-
imeric FokI cleavage domains (FokIELD and FokIKKR). (B) Sanger sequencing 
reads of a PrnpWT and a PrnpZH3 allele from the founder F0 mouse. A deletion 
of 8 bp in the PrnpZH3 allele (highlighted by a red box on the WT sequence) 
introduces a T/D residue change, followed by a premature STOP codon (*) 
after residue 14 within the sequence encoding the PrPC signal peptide. The 
deletion also eliminates the Tsp45I recognition sequence (blue letters on 
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genomic variation between the two analyzed PrnpZH3/ZH3 and 
C57BL/6J individual mice is not dissimilar to the variation 
seen between different individuals of the C57BL/6J strain and 
falls within the natural genetic variation of inbred strains of 
the laboratory mouse. Importantly, we did not identify any 
structural change linked to the targeted Prnp locus on chro-
mosome 2, which would represent a systematic confounder in 
studies comparing PrnpZH3/ZH3 and PrnpWT/WT mice.
PrnpZH3/ZH3 mice lack the flanking gene problem
We next studied the genomic background of PrnpZH3/ZH3 mice. 
Whole-genome single-nucleotide polymorphism (SNP) anal-
ysis of PrnpZH3/ZH3 confirmed that 100% of the analyzed mark-
ers were of the C57BL/6J type (Fig. S2). To further investigate 
the genomic similarity of PrnpZH3/ZH3 mice with C57BL/6J 
mice, we performed RNA sequencing in hippocampi of 
3-mo-old male mice. For additional comparison, we ana-
lyzed hippocampi from congenic aged-matched PrnpZH1/ZH1 
males that had been backcrossed for >12 generations to 
the C57BL/6 background.
In comparison with C57BL/6J mice, PrnpZH1/ZH1 
showed a significantly higher number of variants than 
PrnpZH3/ZH3 (mean number of variants, including SNPs and 
insertions/deletions, IND EL: 3,343 versus. 373; P < 0.01, 
Student’s t test; Fig. 3 A). Notably, the 373 variants detected 
in PrnpZH3/ZH3 included the 8-bp deletion within Prnp exon 
3 (position chr2 :131936464) characteristic of the PrnpZH3 
allele, confirming the accuracy of our procedure for variant 
identification (Fig. S3). By plotting the density of sequence 
variation against its genomic location, we observed an obvious 
clustering of variants in chromosome 2 of PrnpZH1/ZH1 mice, 
with >90% of variants in this chromosome, as expected 
from the inevitable flanking-gene artifacts derived from the 
targeting and breeding strategies in these mice. Crucially, no 
such clustering was observed in PrnpZH3/ZH3 mice (Fig. 3 A).
We then sought to identify genes differentially ex-
pressed between PrnpZH1/ZH1 or PrnpZH3/ZH3 versus 
C57BL/6J hippocampi. The mean Prnp mRNA levels were 
significantly higher in C57BL/6J hippocampi (17,538 reads 
per kilobase per million mapped reads [RPKM]) than in 
PrnpZH1/ZH1 (5,781 RPKM, false discovery rate [fdr]: 3.98 × 
10−85) and PrnpZH3/ZH3 hippocampi (13,278 RPKM, fdr < 
0.01; Fig. S3). Conversely, C57BL/6J, PrnpZH1/ZH1 or 
PrnpZH3/ZH3 did not differ in their mean Prnd levels (4 
RPKM, 5 RPKM, and 2 RPKM, respectively), nor in their 
mean Matts1 levels (26 RPKM, 22 RPKM, and 18 RPKM, 
respectively). The latter observation excludes a systematic 
loss of genomic material comprising the Matts1 locus in the 
PrnpZH3/ZH3 colony. Importantly, we did not identify any 
gene transcribed in C57BL/6J or PrnpZH1/ZH1 hippocampi 
that was not detectable in PrnpZH3/ZH3 hippocampi. This ob-
servation excludes the presence of deletions >100 bp (and as 
such not detectable with our variant identification strategy 
based on sequencing short reads) induced by TAL EN in the 
fraction of the PrnpZH3/ZH3 genome inferred from the 
hippocampus transcriptome.
When plotting the differential expression levels of all 
detectable genes against their genomic location, PrnpZH1/ZH1 
showed obvious clustering of up- and down-regulated genes 
versus C57BL/6J on chromosome 2 (Fig. 3 B). We then fo-
cused on differentially expressed genes (DEGs) with fdr < 0.05 
and absolute log2 ratio > 0.5. Using these filters, we detected 
a significant enrichment of chromosome 2 genes with differ-
ential expression level in PrnpZH1/ZH1 (82 genes, 35 of which 
resided on chromosome 2) as opposed to PrnpZH3/ZH3 mice 
compared with the same C57BL/6J controls (14 genes, none 
of which resided on chromosome 2; P = 0.02, Fisher’s exact 
test, Fig. 3 B). Only two genes are shared between these two 
lists (Tables S3 and S4). This enrichment may reflect sequence 
variations in regulatory elements present in the 129-genomic 
region introgressed in the genome of PrnpZH1/ZH1 mice, which 
results in increased or reduced expression of neighboring genes 
(cis-expression quantitative trait loci [eQTL]; Keane et al., 
2011). This phenomenon is likely to underlie the enrichment 
of chromosome 2 genes among the DEGs between congenic 
PrnpZH1/ZH1 mice and matched WT mice in previous microar-
ray-based transcriptomic analyses (Chadi et al., 2010; Benvegnù 
et al., 2011). A similar phenomenon can be seen in congenic 
lines for other genes, where the chromosome bearing the tar-
geted gene is the one with the highest number of DEGs be-
tween the congenic knockout and WT mice (Ejlerskov et al., 
2015), even though the lack of comparison with a co-isogenic 
mouse does not allow concluding whether this effect is a result 
of the flanking gene problem or not. Also, it is plausible that this 
WT sequence). As a result of sequence characteristics in this region, an 
alternative 8-bp deletion (ACT ATG TG), shifted by 4 bp in respect to the 
previous deletion, is also compatible with the generation of the PrnpZH3 
allele. (C) Representative image of routinely used RFLP analysis discrimi-
nating PrnpWT/WT (digested amplicons), PrnpWT/ZH3 (digested and undigested 
amplicons), and PrnpZH3/ZH3 mice (only undigested amplicon). Primers lo-
cation, restriction site, and expected sizes for digestion products are indi-
cated on top of the gel image. (D) Allelic discrimination genotyping using a 
FAM-labeled WT-specific probe and a Yakima Yellow–labeled ZH3-specific 
probe. NTC, no-template control. ΔRn, difference in normalized reporter 
fluorescence after and before amplification. Apart from NTC, each triangle 
denotes one mouse (n = 4 mice/genotype). The mean (triangle) and SD 
(blue error bars) for four technical replicates of each mouse/NTC sample 
are shown. (E) Immunoblot analysis of PrPC expression in different CNS 
regions (Cx, cortex; Sc, spinal cord; Cb, cerebellum) of PrnpWT/WT (WT) and 
PrnpZH3/ZH3 (ZH3) mice was performed using POM1 (against helices α1 and 
α3 of the PrPC globular domain). The blot was also decorated with anti-ac-
tin antibody as control. (F) Brain PrPC levels as determined by sandwich 
POM1-POM2 ELI SA. PrnpEdbg/Edbg (Edbg) served as negative controls. Each 
circle denotes a mouse (n = 3 mice/genotype). Horizontal bar indicates 
mean. WT→KO, consecutive log2 dilutions of PrnpWT/WT into PrnpEdbg/Edbg 
homogenate, indicating that the threshold of detectability was 1:16. (G) 
Immunofluorescence staining of cerebelli. MAP2 is displayed in green, PrPC, 
detected with POM19 (against helices β1 and α3 of globular domain) in 
red, and DAPI in blue. Bar, 20 µm. (D–G) Representative data from two 
independent experiments.
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effect can become less apparent depending on the functional 
consequence of the gene under investigation and the experi-
mental setup used (Lusis et al., 2007).
Next, we analyzed alternative splicing by assessing the 
presence of differential exon usage between PrnpZH1/ZH1 or 
PrnpZH3/ZH3 versus C57BL/6J hippocampi. We applied similar 
stringent filters used to identify DEGs (with adjusted P value < 
0.05 and absolute log2 ratio > 0.5). Interestingly, we found no 
genes with differential exon usage in PrnpZH3/ZH3 mice com-
pared with C57BL/6J with the applied filters. Conversely, 9 
exons, belonging to 7 genes (6 of which were on chromosome 
2), were differentially expressed between PrnpZH1/ZH1 and 
C57BL/6J mice (Table S5). This enrichment of chromosome 2 
genes among genes with differential exon usage in PrnpZH1/ZH1 
versus C57BL/6J hippocampi likely reflects the presence of 
sequence variants affecting alternative splicing of neighboring 
genes (Hull et al., 2007; Cool et al., 2010). Indeed, the lack 
of enrichment of chromosome 2 genes for loci undergoing 
differential expression or exon usage in PrnpZH3/ZH3 versus 
C57BL/6J hippocampi excludes its dependence from Prnp 
genetic ablation and conversely suggests that this is yet another, 
often neglected, genetic confounder of studies with non–co-
isogenic knockout mice (Suzuki and Nakayama, 2003).
We next analyzed the impact of Prnp genetic ablation in 
vivo on various aspects of RNA metabolisms. Besides genes 
with differential expression and exon usage, we analyzed tran-
scripts undergoing RNA editing. By comparing transcript 
sequences to reference genomic sequences and to published 
databases of RNA-editing sites in mice, we found 271 sites 
Figure 2. C57BL/6-PrnpZH3/ZH3 mice do not have TAL EN off-target 
cleavage sites. T7 endonuclease I digestion of PCR products generated 
from predicted OTs (Table S1) and Prnp as a digestion positive control. 
Analyses were performed on the founder PrnpWT/ZH3 mouse and one control 
C57BL/6J mouse. Before enzymatic digestion, amplicons were subjected to 
a temperature gradient enabling the formation of heteroduplexes in the 
presence of heterozygous mutations in the amplified gDNA. In the pres-
ence of TAL EN-induced mutations, fragments of the size indicated below 
the gels are expected to appear, in addition to the undigested, WT ampl-
icon. Nonconsecutive lanes from the same gel show Prnp amplicon as a 
control. Only in the founder PrnpWT/ZH3 mouse T7 endonuclease I digestion 
of the Prnp amplicon results in the formation of the two predicted frag-
ments (indicated by an asterisk).
Figure 3. RNA sequencing in PrnpWT/WT, 
PrnpZH1/ZH1, and PrnpZH3/ZH3 hippocampi. 
RNA sequencing was performed on hippo-
campi from four mice per each group. (A) 
Physical distribution of sequence variant 
density across the genome based on variants 
unique to PrnpZH1/ZH1 (ZH1, left) or PrnpZH3/ZH3 
(ZH3, right) compared with C57BL/6J mice 
(BL6). Each dot denotes the ratio of vari-
ants and total number of annotated bases 
in 50-kb windows throughout the genome. 
Pie charts depict the number (n, proportional 
to the area) and chromosomal distribution 
(yellow, chromosome 2; gray, other chromo-
somes) of sequence variants in the two com-
parisons. For variant identification, the three 
mice with the highest coverage within each 
group were considered. (B) Physical distri-
bution of differential gene expression levels 
across the genome based on the comparison 
of PrnpZH1/ZH1 (left) or PrnpZH3/ZH3 (right) with 
respect to C57BL/6J mice. Each dot denotes 
a gene. Pie charts depict the number (n, pro-
portional to the area) and chromosomal dis-
tribution (yellow, chromosome 2; gray, other 
chromosomes) of DEGs (fdr < 0.05 and abso-
lute log2 ratio > 0.5) in the two comparisons.
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with evidence for RNA editing in PrnpZH1/ZH1, PrnpZH3/ZH3, 
and/or C57BL/6J hippocampi. Compared with C57BL/6J, 
three sites in PrnpZH1/ZH1 and seven sites in PrnpZH3/ZH3 hip-
pocampi showed a significantly different level of RNA ed-
iting (P < 0.05; Fig. 4, A and B; and Tables S6 and S7). We 
then selected three of these sites (mapped to Gria2, Grik2, 
and Rbm4b) and performed Sanger sequencing of gDNA 
from the mice included in the RNA sequencing experiment. 
This analysis confirmed the presence, in homozygosity, of the 
expected, reference nucleotide (Fig. S4), thereby excluding 
that the observed mismatch in the RNA reads might be a 
result of DNA polymorphisms, rather than RNA editing. In 
all cases in which sites could be assigned to a gene, edited sites 
were found to be present in noncoding regions. Also, in all 
but one of these cases, one adenosine in the reference genome 
was found to be replaced by a guanosine in the sequenced 
reads (Fig. 4 B), which is in line with an adenosine-to-inosine 
RNA-editing process (Li and Church, 2013). Sites with dif-
ferential RNA editing between C57BL/6J and PrnpZH3/ZH3 
hippocampi included two intronic sites belonging to genes 
(Grik2 and Gria2) encoding for members of the kainate fam-
ily of glutamate receptors (Fig. 4 B). RNA editing in these in-
tronic positions of these genes have been previously reported 
(Stilling et al., 2014), whereas editing in the coding regions of 
Grik2 and Gria2 transcripts significantly affects protein func-
tion (Sommer et al., 1991; Silberberg et al., 2012). It will be of 
interest to test whether any of these changes might be related 
to the currently debated role of PrPC in kainate-induced ex-
citotoxicity (Striebel et al., 2013; Carulla et al., 2015).
In the case of PrnpZH1/ZH1 versus C57BL/6J hippocampi, 
there was one gene, Wdr76, on chromosome 2, with evidence 
of both differential expression and exon usage (Fig. 4 A and 
Tables S3 and S5). No such changes were detected between 
PrnpZH3/ZH3 and C57BL/6J hippocampi. Wdr76 is mapped 
on chromosome 2, ∼10 Mb apart from Prnp, and is highly 
polymorphic between C67BL/6 and 129 strains, with nu-
merous SNPs between these strains, including a coding 
nonsynonymous one (rs27425186; Mouse Phenome Data-
base). Interestingly, Wdr76 plays a role in the recovery from 
genotoxic stress (Gallina et al., 2015) and congenic B6.129- 
PrnpZH1/ZH1 mice have been recently shown to have a defec-
tive repair of induced DNA damage in the brain compared 
with C57BL/6N WT mice (Bravard et al., 2015). It will be of 
interest to investigate to what extent the observed phenotype 
can be influenced by differences in Wdr76 expression, splicing 
and coding sequence between the two examined genotypes.
A subset of genes with differential expression is repre-
sented by transcripts known to be enriched in different cell 
types of the CNS (Fig. 4 A). When analyzing the 82 genes 
found to be differentially expressed between C57BL/6J and 
PrnpZH1/ZH1 hippocampi, PrnpZH3/ZH3 showed an overall pat-
tern of expression closer to the one of C57BL/6J hippocampi 
(Fig. 4 C). Analogously, for the 14 DEGs between C57BL/6J 
and PrnpZH3/ZH3 hippocampi, PrnpZH1/ZH1 showed an overall 
expression profile closer to the one of C57BL/6J hippocampi. 
Pathway analysis based on these 14 DEGs did not identify 
any canonical pathway associated with more than 2 DEGs. 
However, it is of interest that several of these 14 DEGs are 
associated with immunological functions (e.g., Icam1, C1qb, 
Itga7, Sele, and Spsb1).
Collectively, these observations highlight, at a molecular 
level, that congenic PrnpZH1/ZH1 and co-isogenic PrnpZH3/ZH3 
mice are largely divergent and that, in PrnpZH1/ZH1 mice, a con-
spicuous proportion of the observed transcriptional changes is 
related to genes on chromosome 2, where an ES cell–derived ge-
nomic region (of 129 type) is retained. Moreover, these data con-
firm that PrnpZH3/ZH3 mice have a bona fide C57BL/6J genome, 
including the region flanking Prnp, and therefore are devoid of 
the flanking gene problem affecting other non–co-isogenic lines.
PrnpZH3/ZH3 macrophages do not show 
enhanced phagocytic activity
Hyperphagocytosis of apoptotic cells in primary macrophages 
from non–co-isogenic Prnp−/− lines was originally attributed 
to the absence of Prnp (de Almeida et al., 2005), but was later 
shown to be the result of a flanking gene problem (Nuvolone 
et al., 2013). We measured the phagocytic activity of primary 
BM-derived C57BL/6J and PrnpZH3/ZH3 macrophages exposed 
to apoptotic thymocytes. Congenic PrnpZH1/ZH1 macrophages 
were included as controls. In line with our previous observations 
(Nuvolone et al., 2013), we found increased phagocytic activ-
ity only in PrnpZH1/ZH1 macrophages, but not in PrnpZH3/ZH3 
macrophages (Fig. 5 A and Fig. S5).
PrnpZH3/ZH3 mice do not display Prnd overexpression and 
associated neurodegeneration
Purkinje cell degeneration in the cerebellum and associated 
ataxia, starting from the age of 6 mo, is a hallmark of several 
lines of Prnp-ablated mice and is caused by inappropriate in-
tergenic splicing and overexpression of the neighboring Prnd 
gene (Moore et al., 1999). We monitored PrnpZH3/ZH3 mice for 
the occurrence of similar neurodegenerative changes. 10–14- 
mo-old PrnpWT/WT and PrnpZH3/ZH3 littermates showed similar 
walking patterns as assessed by the footprint test (Fig. 5, B and 
C), and similar performance in the rotarod test (Fig. 5 D). At 
15 mo of age, no significant loss of Purkinje cells was evident 
(Fig. 5 E). Also, quantitative real-time PCR (qRT-PCR) showed 
brain levels of Prnd transcripts similar between PrnpWT/WT and 
PrnpZH3/ZH3 mice (Fig. 5 F), in line with the RNA sequencing 
data. Collectively, these data indicate that PrnpZH3/ZH3 mice did 
not experience any significant perturbation of Prnd expression 
and its associated neurodegeneration observed in four of the 
previously generated Prnp−/− lines.
PrnpZH3/ZH3 mice develop a chronic 
demyelinating peripheral neuropathy
Progressive chronic demyelinating polyneuropathy (CDP) is 
a robust phenotype present in all examined Prnp−/− lines, in-
cluding co-isogenic PrnpEdbg/Edbg mice, and results from the 
absence of neuronal PrPC expression (Bremer et al., 2010). 
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Figure 4. Impact of Prnp genetic ablation on RNA metabolism in vivo. RNA sequencing was performed on hippocampi from four mice per each 
group. (A) Pie charts depict the number (proportional to the area) of genes showing differential expression (expression), exon usage (splicing), or RNA 
editing levels (editing) between PrnpZH1/ZH1 (ZH1, left) or PrnpZH3/ZH3 (ZH3, right) and C57BL/6J mice. Colors indicate genes known to be enriched in specific 
cell types of the central nervous system. (B) Sites with differential RNA-editing levels between PrnpZH1/ZH1 (left) or PrnpZH3/ZH3 (right) and C57BL/6J mice. 
Editing level indicates percentage of reads showing an edited base instead of the canonical base. Each dot denotes one mouse. This analysis is based on 
the three mice with the highest coverage for each group. Horizontal bar indicates mean. For sites assigned to a gene (indicated with the gene name), the 
lower nucleotide indicates the edited base and the upper nucleotide the reference base. The other sites are indicated with their genomic location. One site 
(indicated as Ovca2) is mapped to two neighboring genes (Ovca2 and Mir684-1) on the same strand. (C) Heat map of genes with differential expression 
levels between PrnpZH1/ZH1 (left) or PrnpZH3/ZH3 (right) and C57BL/6J mice. Each row represents one mouse. Two genes (Tmem-181b-ps and Tmem-181c-ps) 
are common to both comparisons.
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We analyzed the integrity of peripheral nerves in PrnpZH3/ZH3 
mice and found a trend toward increased CD68+ digestion 
chambers (indicative of myelin degradation and resorption by 
macrophages) in the sciatic nerves of 3-mo-old PrnpZH3/ZH3 
mice that reached statistical significance at 9 mo (Fig. 6, A and 
B). At 14 mo of age, PrnpZH3/ZH3 mice showed a significant 
reduction of axonal density in sciatic nerves as compared with 
PrnpWT/WT (Fig. 6, C and D), as well as ultrastructural signs of 
demyelination (Fig. 6 E). All these features strongly resemble 
the changes described in sciatic nerves of other previously ex-
amined Prnp−/− lines and confirm the crucial involvement of 
PrPC in peripheral myelin maintenance (Bremer et al., 2010).
PrnpZH3/ZH3 mice as a genetic resource for prion science
Overall, these data confirm that PrnpZH3/ZH3 mice lack the 
genetic confounders and artifactual phenotypes of non–
co-isogenic Prnp−/− lines. Because of the stringent genetic 
controls described above, PrnpZH3/ZH3 mice constitute an 
unprecedented genetic tool for elucidating the physiological 
function of PrPC and its involvement in pathological condi-
tions. This line will be particularly well suited to intercross-
ing and/or comparing with other genetically modified mice 
raised on the well-characterized C57BL/6 background. Our 
institution will be pleased to provide unrestricted access to 
PrnpZH3/ZH3 mice for noncommercial purposes.
Figure 5. C57BL/6J-PrnpZH3/ZH3 mice do 
not show artifactual phenotypes of other 
Prnp−/− lines. (A) Rate of phagocytosis of 
BMDM obtained from C57BL/6J (BL6) and 
PrnpZH3/ZH3 mice (ZH3) and exposed to different 
numbers of apoptotic thymocytes (indicated 
as thymocytes to BMDM ratios). Macrophages 
from PrnpZH1/ZH1 mice (ZH1) served as control. 
Each dot denotes a macrophage well exposed 
to thymocytes (n = 8 macrophage wells/ 
genotype/condition). Values were normalized 
to the rate of phagocytosis in C57BL/6J mice 
with 10 thymocytes to BMDM ratio (mean set 
as 100%). Horizontal bar indicates mean. Data 
are from two independent experiments. n.s.: 
not significant; two-way ANO VA, Bonferroni’s 
multiple comparisons test. (B) Representa-
tive images of footprints from 10–14-mo-old 
PrnpWT/WT and PrnpZH3/ZH3 mice. Magenta, fore 
paw; blue, hind paw. (C) Quantification of dif-
ferent gait parameters. Each circle denotes a 
mouse (n = 6 mice/genotype). Horizontal bar 
indicates mean. n.s., not significant; Student’s 
t test. (B and C) are representative data from 
two/three trials. (D) Latency to fall at the ro-
tarod test in PrnpWT/WT and PrnpZH3/ZH3 mice. 
Mice were 10–14-mo-old at test 1 and test 2 
was performed 1 mo after. Each circle denotes 
a mouse (n = 6 mice/genotype). Horizontal 
bar indicates mean. n.s., no significant differ-
ence between genotypes, two-way ANO VA. 
(E) Representative images of hematoxylin and 
eosin (H & E) staining of cerebelli of 60-wk-
old PrnpWT/WT and PrnpZH3/ZH3 mice (n = 3 and 
8 mice, respectively). 63-wk-old PrnpZH2/ZH2 
mice served as control (n = 2 mice). Bar, 50 
µm. Data are from two experiments. (F) Brain 
Prnd mRNA levels as determined by qRT-PCR. 
Values were normalized to levels in testis of 
PrnpWT/WT mice (mean set as 1). PrnpEdbg/Edbg 
(Edbg) and PrnpNgsk/Ngsk (Ngsk) served as neg-
ative and positive controls, respectively. Each 
circle denotes a mouse (n = 4 mice for Ngsk 
and n = 3 mice for all other genotypes). Hori-
zontal bar indicates mean.
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The strategy exemplified in the generation and charac-
terization of PrnpZH3/ZH3 mice carries implications beyond 
the prion community. The majority of studies involving 
knockout mice are based on non–co-isogenic, ES cell– 
derived knockout lines. However, unmatched genetic back-
ground between such knockout mice and WT counterparts 
(even when using littermates from heterozygous breedings) 
is unavoidable in these cases and this situation often gives 
rise to serious and systematic genetic confounders (Vanden 
Berghe et al., 2015). Common efforts to target each gene of 
the mouse genome in C57BL/6-derived ES cells (Collins 
et al., 2007) represent a valid strategy to prevent these prob-
lems. Moreover, the recent availability of genome-editing 
techniques, including the TAL EN technique presented here, 
is now enabling the rapid and simple manipulation of the 
mouse genome. Our study demonstrate that this approach 
may also be applicable to genes for which knockout mice 
are already available (and extensively characterized), thereby 
generating improved genetic models and disproving poten-
tially misattributed physiological functions.
MAT ERI ALS AND MET HODS
Ethical statement. Animal care and experimental protocols 
were performed in compliance with the Swiss Ethical Princi-
ples and Guidelines for Experiments on Animals, the Swiss 
Animal Protection Law, and with the internal guidelines of 
the University of Zurich, under the approval of the Veterinary 
Office of the Canton Zurich (animal permits Versuchstierhal-
Figure 6. C57BL/6J-PrnpZH3/ZH3 mice de-
velop a chronic demyelinating periph-
eral neuropathy. (A) Representative images 
of CD68 staining of longitudinal sections of 
sciatic nerves show digestion chambers of 
macrophages and myelin debris in PrnpZH1/ZH1 
(ZH1), PrnpZH3/ZH3 (ZH3), and PrnpWT/WT(WT) 
mice at 3 and 9 mo of age. Bar, 50 µm. (B) Cor-
responding quantification of CD68+ digestion 
chambers in sciatic nerves at the same time 
points as in A. Each dot denotes a mouse (n 
= 4–6 mice/genotype/time point). Horizontal 
bar indicates mean. n.s., not significant; ****, 
P < 0.0001. One-way ANO VA, Bonferroni’s 
multiple comparisons test. (C) Representative 
images of toluidine blue staining of semi-thin 
cross-sections of sciatic nerves from PrnpWT/WT 
and PrnpZH3/ZH3 mice at 14 mo of age. Bar, 50 
µm. (D) Corresponding quantification of den-
sity of axons of different size in sciatic nerves 
of 14-mo-old mice (WT, n = 3 mice; ZH3, n = 
8 mice). Symbols indicate mean, whiskers in-
dicate minimum and maximum values. Two-
way ANO VA shows a significant effect (P < 
0.0001) of genotype. (E) Representative images 
of transmission electron microscopy of cross 
sections from sciatic nerves of 14-mo old mice 
(WT, n = 3 mice; ZH3, n = 4 mice). Arrows indi-
cate thinly myelinated axons. Bar, 10 µm. (A–E) 
Data from two experiments.
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tung 123, 90/2013). All efforts were made to minimize animal 
discomfort and suffering.
Mice. The following mice were studied: PrnpZH1/ZH1 mice 
(Büeler et al., 1992) backcrossed to C57BL/6 for >12 
generations; PrnpZH2/ZH2 mice (Rossi et al., 2001) on a mixed 
B6129 background; PrnpEdbg/Edbg mice on a pure 129/Ola 
background (Manson et al., 1994) and co-isogenic WT 129/
Ola mice, both provided by J. Manson, H. Baybutt, and N.A. 
Mabbott (University of Edinburgh, Edinburgh, Scotland, UK); 
PrnpNgsk/Ngsk mice (Sakaguchi et al., 1995) extensively 
backcrossed to C57BL/6; PrnpGFP/GFP mice (Heikenwalder et 
al., 2008) backcrossed to C57BL/6 for 10 generations provided 
by W. Jackson (Deutsches Zentrum für Neurodegenerative 
Erkrankungen, Bonn, Germany) and S. Lindquist (Massachusetts 
Institute of Technology, Cambridge, MA); WT C57BL/6J and 
Crl :CD1(ICR) mice purchased from The Jackson Laboratory, 
Charles River, or bred in-house. Genetically vasectomized 
mice (Haueter et al., 2010) were maintained in house. 
Genotypes were verified by PCR on DNA obtained from ear 
punches as indicated in the original description of each line. All 
animals were maintained in temperature- and light-controlled 
rooms (12 light/12 dark) with food and water ad libitum in a 
high-hygienic grade facility. Mice were euthanized by cervical 
dislocation, followed by decapitation, or anesthetized with 
ketamine-xylazine and transcardially perfused with a solution 
of PBS containing heparin, unless otherwise specified. Archival 
material, including paraffin-embedded tissues and gDNA 
samples originally described in previous studies (Genoud et al., 
2004; Nuvolone et al., 2013), was also analyzed. Archival gDNA 
samples included material provided by the Institute of Physical 
and Chemical Research (Saitama, Japan).
Genome editing in mouse embryos. Design of TAL EN- 
targeting strategy was based on the employment of second- 
generation heterodimeric FokI cleavage domains fused to a 
truncated TALE C terminus for improved specificity and cleav-
age efficiency and microinjections were performed as previ-
ously described (Hermann et al., 2014).
The TAL EN target sites 5′-TGG CTG CTG GCC 
CTCT-3′ and 5′-TGC AGA GGC CGA CAT CA-3′ within 
the Prnp protein coding sequence were identified using the 
TAL EN-NT algorithm (Doyle et al., 2012). TALE-NT was 
also used to predict potential OTs for the Prnp TAL EN pair 
and the 8 PCR-accessible out of the 12 top-scoring sites 
were selected for further analysis. TAL ENs were assembled 
using the Golden Gate TAL EN and TAL Effector kit (plas-
mid kit 1000000024; Addgene; Cermak et al., 2011) and the 
pCAG-T7 heterodimeric TAL EN destination vectors (plas-
mids 40131 and 40132; Addgene; Hermann et al., 2014). 
In vitro mRNA transcription, capping, and polyadenylation 
were performed using the mMES SAGE mMAC HINE T7 
Ultra kit. Before injection, the mRNAs were purified using 
NucAway Spin Columns (Ambion). mRNA quality was 
verified by denaturing gel electrophoresis; concentration 
was determined by spectrophotometry. Microinjection of 
C57BL/6J embryos with Prnp TAL EN mRNAs at a con-
centration of 100 ng/µl resulted in gene modification in 
>40% of founder animals as previously described (Hermann 
et al., 2014). In the present study, a concentration of 10 ng/
µl was employed. C57BL/6J female mice underwent ovu-
lation induction by i.p. injection of 5 IU equine chorionic 
gonadotrophin (PMSG; Folligon–InterVet), followed by i.p. 
injection of 5 IU human chorionic gonadotropin (Pregnyl– 
Essex Chemie) 48  h later. For the recovery of zygotes, 
C57BL/6J females were mated with males of the same strain 
immediately after the administration of human chorionic 
gonadotropin. All zygotes were collected from oviducts 
24  h after the human chorionic gonadotropin injection, 
and were then freed from any remaining cumulus cells by a 
1–2 min treatment of 0.1% hyaluronidase (Sigma-Aldrich) 
dissolved in M2 medium (Sigma-Aldrich). Mouse em-
bryos were cultured in M16 (Sigma-Aldrich) medium at 
37°C and 5% CO2. For micromanipulation, embryos were 
transferred into M2 medium.
All microinjections were performed using a microinjection 
system comprised of an inverted microscope equipped 
with Nomarski optics (Nikon), a set of micromanipulators 
(Narashige), and a FemtoJet microinjection unit (Eppendorf). 
TAL EN mRNAs were injected at a concentration of 10 ng/
µl into the cytoplasm of fertilized mouse oocytes. Embryos 
that survived the microinjection were transferred on the same 
day into the oviducts of 8–16-wk-old pseudopregnant Crl 
:CD1(ICR) females (0.5 d used after coitus) that had been 
mated with sterile genetically vasectomized males (Haueter 
et al., 2010) the day before embryo transfer. Pregnant females 
were allowed to deliver and raise their pups until weaning age.
Identification of nonhomologous end-joining–modified 
alleles. gDNA was extracted from tissue biopsies using a 
buffer containing 10 mM Tris-HCl, pH 9.0, 50 mM KCl, 
0.45% Nonident p40, 0.45% Tween-20, and Proteinase 
K. For detecting nonhomologous end-joining–mediated 
insertions/deletions, amplicons of the Prnp locus and 
selected potential TAL EN off-target cleavage sites were 
generated using appropriate primers (listed in Table S2) 
and Herculase II Fusion DNA Polymerase (Agilent Tech-
nologies) using the following conditions: 95°C for 2 min, 
35 cycles of 95°C for 30  s, 63°C for 30  s (with a ramp 
of −0.75°C/cycle for the first 20 cycles and a constant 
temperature of 48°C for the remaining 15 cycles), 72°C 
for 20  s, and 72°C for 3 min. PCR products were puri-
fied using the QIAquick PCR Purification kit (QIA GEN) 
and subjected to heteroduplex formation using the fol-
lowing conditions in a thermocycler: 95°C 2 min, 95°C 
to 85°C (−2°C/s), and 85°C to 25°C (−0.1°C/s), and 
then digested with T7 endonuclease (NEB) for 20 min at 
37°C. Digestion products were resolved on a 2% agarose 
gel. For Sanger sequencing, PCR products were cloned 
into pGEM-T easy (Promega).
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Allelic discrimination assay. To distinguish WT from ZH3 al-
leles of Prnp, an amplicon encompassing the 8 bp deletion 
was generated in the presence of two TaqMan probes, each 
one specific for the WT or the ZH3 allele and carrying a 
different fluorophore at the 5′ end (FAM and Yakima Yellow, 
respectively) and the BHQ1 quencher at the 3′ end (primers 
and probes sequences in Table S2) using TaqMan Universal 
PCR Master Mix, No AmpErase UNG on a ViiA 7 Real- 
Time PCR System following a standard genotyping pro-
tocol (Life Technology).
RFLP analysis. To distinguish WT versus ZH3 alleles of Prnp, 
gDNA was PCR amplified using primers listed in Table S2. 
Amplicons were digested with Tsp45I, and digestion products 
were separated by electrophoresis on an agarose gel.
G-banding and spectral karyotyping. Mouse ear biopsies 
were cut into small pieces, and then incubated first with col-
lagenase (Sigma-Aldrich) at 37°C for 1  h, and then with 
0.05% Trypsin/0.53 mM EDTA (Wisent) at 37°C for 30 min. 
Cells were then cultured in α-MEM, 15% FBS, and antibiot-
ics (GE Healthcare) for 1 wk, subcultured into 60-mm dishes 
until 80% confluence, incubated in 0.05 µg/ml colcemid (In-
vitrogen) for 20 min, trypsinized, pelleted, incubated in 
75 mM KCl hypotonic solution at 37°C for 1 h, and fixed in 
3:1 methanol/glacial acetic acid fixative. Mouse spleen was 
flushed with RPMI 1640, 250 mM Hepes, 10% FBS, 2 mM 
l-glutamine, and antibiotics (GE Healthcare), splenocytes 
were filtered, and cultured in the presence of 50 µg/ml LPS 
(Sigma-Aldrich) at 37°C for 72 h. Cells were then incubated 
in 0.05 µg/ml colcemid (Invitrogen) for 15 min, pelleted, in-
cubated in 75 mM KCl hypotonic solution at 37°C for 1 h 
and fixed in 3:1 methanol/glacial acetic acid fixative. Cell sus-
pensions were dropped onto slides in a Thermotron, aged 
overnight, G-banded and imaged, destained, denatured, and 
then hybridized overnight with denatured mouse spectral 
karyotyping reagent (Applied Spectral Imaging), washed, and 
counterstained with DAPI. For splenocytes, the steps for 
spectral karyotyping were omitted.
Image acquisition was performed with an Olympus 
BX61 microscope (Olympus) equipped with a SpectraCube 
SD300 (Applied Spectral Imaging) consisting of an optical 
head with a special Fourier-transform spectrometer, and 
a cooled CCD camera COOL-1300QS (VDS Vosskühler 
GmbH). Samples were illuminated with a xenon lamp 
Lambda LS (Sutter Instrument Company) through a Lambda 
10-B optical filter changer with SmartShutter (Sutter In-
strument Company) and imaged with a 60×/N.A. 1.42 oil 
immersion objective (Olympus). Images, typically consisting 
of a built from 128 frames of 600 ms, were acquired using 
Spectral Imaging acquisition software Version 4.5 (Applied 
Spectral Imaging). DAPI images were acquired separately. 
G-banded samples were imaged with a CCD camera (VDS 
Vosskühler GmbH) on the Olympus BX61 microscope set 
in bright-field mode with a 100×/N.A. 1.40 oil immersion 
objective (Olympus). To optimize contrast, a green filter was 
inserted in the illumination pathway. Spectral karyotyping 
images were analyzed using SkyView Version 2.1.1 (Ap-
plied Spectral Imaging).
Array comparative genome hybridization. gDNA was ex-
tracted from mouse tissue using QIAamp DNA mini kit 
(QIA GEN) and 1 µg of purified gDNA was labeled using the 
CytoSure Genomic DNA Labeling kit (Oxford Gene Tech-
nology), according to the manufacturers’ instructions. Cy3-la-
beled C57BL/6J reference and cy5-labeled PrnpZH3/ZH3 
experimental sample were hybridized with SurePrint G3 
Mouse CGH Microarray kit, 1 × 1 M (Agilent Technologies) 
according to manufacturer’s instructions. The 1 × 1 M array 
consists of 963,261 distinct 60-mer oligonucleotide probes, 
plus 1,000 replicates and an additional 6,745 quality control 
features, resulting in an 1.8-kb overall median spacing (1.5 kb 
in Ref-Seq genes; Agilent Technologies). Data were analyzed 
using Agilent Genomic Workbench 7.0.4.0 software (Agilent 
Technologies). Probes were annotated against the UCSC 
mm9 (NCBI Build 37) genome build. After a quality-control 
step, variant calling was performed using the aberration algo-
rithm ADM-2 with the following filters: threshold 10.0, win-
dows size 2 kb, diploid peak centralization ON, fuzzy zero 
ON, GC correction ON, combine replicates (intra-assay) 
ON, minimum number of probes 10, minimum average 
absolute log2 ratio ≥0.3.
Whole-genome SNP analysis. gDNA was purified from tail 
biopsies or ear punches using the Gentra Puregene Mouse 
Tail kit (QIA GEN) according to manufacturer’s instructions. 
Whole-genome SNP analysis (Taconic Laboratories) was 
performed using the Illumina Mouse MD Linkage Panel 
array consisting of 1,449 strain-informative SNP mark-
ers spanning the whole genome (at least three SNPs every 
5 Mb, with at least one SNP informative for C57BL/6J 
versus other strains; Illumina). Results were compared 
with data from reference strains (129S6/SvEvTac, C57BL/
6JBomTac, and C57BL/6NTac).
qRT-PCR. RNA was isolated from snap frozen tissues using 
the RNeasy mini kit (QIA GEN). RNA concentration and 
quality were determined with NanoDrop (Thermo Fisher 
Scientific). Reverse transcription was performed using the 
QuantiTect Reverse Transcription kit (QIA GEN), according 
to the manufacturer’s instructions. qRT-PCR was performed 
on a ViiA 7 Real-Time PCR System (Life Technology). Am-
plification was performed with Fast Start SYBR Green Mas-
ter (ROX; Roche) with 0.5 µM of each forward and reverse 
primers for the target of interest or appropriate normalization 
genes (Table S2) and cDNA as template, using the following 
conditions: 50°C for 2 min, 95°C for 10 min, 40 cycles of 
95°C for 15 s, and 60°C for 1 min. After each run, a melting 
curve analysis was performed, using the following conditions: 
95°C for 15 s, 60°C for 1 min, and 95°C for 15 s. For all steps, 
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a ramp rate of 1.6°C/s was used. Raw Ct values were used to 
calculate relative expression levels of target genes, after nor-
malization to three internal control genes (Eif2a, Utpc6, and 
Gapdh) according to geNorm (Vandesompele et al., 2002). 
Eif2a and Utpc6 primer sequences were originally reported 
in (Kosir et al., 2010); Gapdh primer sequences were obtained 
from the Genomics Platform–University of Geneva.
RNA sequencing. Mice under deep anesthesia were transcar-
dially perfused with ice-cold PBS heparin treated with di-
ethylpyrocarbonate. Hippocampi were immediately dissected 
with the help of an adult mouse brain slicer matrix (Zivic 
Instruments), snap frozen, and kept –80°C until homogeniza-
tion. Total RNA was isolated using the RNeasy Plus universal 
mini kit (QIA GEN), snap frozen, and kept at –80°C until 
further analysis. Library preparation for RNA sequencing was 
performed, as previously described (Nuvolone et al., 2013) 
with modifications. RNA quality was assessed using Bioan-
alyzer 2100 (Agilent Technologies) and Qubit (1.0) Fluo-
rometer (Life Technologies). Only samples with a 28S/18S 
ratio between 1.5 and 2 and a 260 nm/280 nm ratio be-
tween 1.8 and 2.1 were further processed. The TruSeq RNA 
Sample Prep kit v2 (Illumina) was used in the subsequent 
steps. In brief, 1 µg of total RNA per sample was poly A– 
enriched, reverse transcribed into double-stranded cDNA 
and ligated with TruSeq adapters. PCR was performed to se-
lectively enrich for fragments containing TruSeq adapters on 
both ends. Quality and quantity of enriched libraries were 
analyzed using Qubit (1.0) Fluorometer and Caliper GX 
LabChip GX (Caliper Life Sciences). The resulting product 
is a smear with a mean fragment size of ∼260 bp. Libraries 
were normalized to 10 nM in Tris-Cl 10 mM, pH 8.5, with 
0.1% (vol/vol) Tween 20.
TruSeq PE Cluster kit v4-cBot-HS (Illumina) was 
used for cluster generation using 2 pM of pooled normal-
ized libraries on the cBOT. Sequencing was performed 
on Illumina HiSeq 2500 at 1 × 100 bp using the TruSeq 
SBS kit v4-HS (Illumina).
RNA sequencing data analysis was performed as previ-
ously described (Nuvolone et al., 2013), with minor modifica-
tions. Reads were quality-checked using FastQC. Low-quality 
ends were clipped (5′, 3 bases; 3′, 10 bases). Trimmed reads 
were aligned to the reference genome and transcriptome 
(FAS TA and GTF files, respectively, downloaded from the 
Ensembl GRCm38) with STAR version 2.3.0e_r291 (Dobin 
et al., 2013) with default settings. Loci with mismatches with 
respect to the reference genome were detected following the 
best practice workflow to identify variants from RNA se-
quencing data using GATK version 3.4.0 (DePristo et al., 
2011). This analysis was performed on the three mice with 
the highest sequencing coverage for each group and only 
mismatches in common to all three mice in each group were 
considered. Sequence mismatches were dichotomized as ei-
ther RNA-editing sites if present in a previously published 
catalog of 17`831 RNA editing sites in mice (Stilling et al., 
2014) or otherwise as variants. Variants were annotated using 
snpEFF version 3.4 (Cingolani et al., 2012), and distribution 
of the reads across genomic isoform expression was quantified 
using the R package GenomicRanges (Lawrence et al., 2013) 
from Bioconductor Version 3.0. DEGs were identified based 
on fdr values using the R package edgeR (Robinson et al., 
2010) from Bioconductor Version 3.0. Differential exon usage 
was detected based on adjusted P values with the DEXSeq 
R-package (Anders et al., 2012) using default parameters. Vi-
sualization of RNA sequencing coverage was performed using 
Integrative Genome Viewer (Robinson et al., 2011). Pathway 
analysis was performed using Ingenuity Pathway Analysis (In-
genuity Systems). Data from RNA sequencing analyses have 
been deposited to GEO under the dataset code GSE75510.
A list of genes enriched in neurons, astrocytes, oligo-
dendrocytes, microglia and CNS endothelial cells (500 genes 
per cell type) was retrieved using the cell type enrichment 
query from a transcriptomic based database, (Zhang et al., 
2014), searching for genes enriched in one cell type respect 
to all others. In the case of oligodendrocytes, oligodendro-
cytes precursor cells, newly formed oligodendrocytes and 
myelinating oligodendrocytes were considered together. The 
resulting, nonoverlapping lists of CNS cell type enriched 
genes were used for comparisons with the lists of genes with 
differential gene expression, exon usage, and RNA edit-
ing in the present study.
Sequencing of gDNA. GDNA was extracted as from tissue 
biopsies using a buffer containing 10 mM Tris-HCl, pH 9.0, 
50 mM KCl, 0.45% Nonident p40, 0.45% Tween-20 and Pro-
teinase K. Target regions were amplified by PCR using ap-
propriate primers (listed in Table S2) under the following 
conditions: 2 min at 94°C; 35 cycles of 30 s at 94°C, 30 s at 
58°C, and 45 s at 72°C; 5 min at 72°C. Amplicons were sub-
jected to agarose gel electrophoresis and DNA was purified 
from excised bands using the Nucleospin Gel and PCR 
Cleanup kit (Macherey-Nagel), according to manufacturer’s 
instructions. Sanger sequencing was performed at Microsynth 
AG, using the same primer pair used for PCR amplification.
Western blotting. Snap-frozen tissues were used to prepare 
10% (w/vol) homogenates in RIPA buffer (25 mM Tris-HCl, 
pH 7.6, 150 mM NaCl, 1% Nonident p40, 1% sodium deoxy-
cholate, and 0.1% SDS) + cOmplete Mini Protease Inhibitor 
Cocktail (Roche) using 5-mm stainless steel beads (QIA GEN) 
and Tissue Lyser LT (QIA GEN). Total protein concentration 
was measured using the BCA Protein Assay (Thermo Fisher 
Scientific) according to the manufacturer’s instructions. 20 µg 
of total protein homogenates in NuPAGE LDS sample buffer 
(Invitrogen) with β-mercaptoethanol as reducing agent were 
separated on a NuPAGE 12% Bis-Tris (Invitrogen) and trans-
ferred onto a Protran Nitrocellulose Transfer Membrane 
(Whatman) using the NuPAGE Gel Electrophoresis System 
(Invitrogen) according to the manufacturer’s instructions. Pre-
cision Plus Protein Dual Color Standards (Bio-Rad Laborato-
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ries) and MagicMark XP Standard to Antibodies (Invitrogen) 
were used as molecular weight ladder. Membranes were subse-
quently blocked with 5% w/vol Top-block (Fluka) in TBS sup-
plemented with 0.1% vol/vol Tween-20 (TBST). Antibodies 
were incubated in 1% wt/vol Top-block (Fluka) in TBST. Pri-
mary antibodies used were: anti-PrPC mouse monoclonal anti-
bodies POM1 (280 ng/ml; Polymenidou et al., 2008) and 
anti-actin mouse monoclonal antibody, Clone C4 (1:8,000; 
EMD Millipore). HRP-conjugated goat anti–mouse IgG 
(H+L; 1:17,000 dilution; Invitrogen) was used as secondary an-
tibody. Blots were developed using Luminata Western HRP 
Substrates (EMD Millipore) and visualized using the 
Stella detector (Raytest).
PrPC ELI SA. PrPC was quantified in tissue homogenates by 
sandwich ELI SA using POM1 and POM2 antibodies as pre-
viously described (Polymenidou et al., 2008).
Footprint test. The footprint test was performed as previously 
described (Carter et al., 1999), with minor modifications. To 
obtain footprints, the fore and hind feet of the mice were 
painted with magenta and blue nontoxic inks, respectively. 
Mice were then allowed to walk along a 90-cm long, 7-cm 
wide, 20-cm high corridor on a fresh white paper. Mice had 
up to three trials. Footprints were analyzed for the following 
parameters, as previously described (Carter et al., 1999): stride 
length (mean distance of footprints from the same paw in 
consecutive strides); hind-base width (mean distance between 
right and left hind footprints); front-base width (mean dis-
tance between right and left front footprints); and front/hind 
footprint overlap (mean distance between hind footprint and 
the preceding front footprint). Footprints at the beginning 
and at the end of the corridor were excluded. For each step 
parameter, 4–12 values were measured and the mean was cal-
culated and used for analysis. The operator was 
blind to mouse genotype.
Rotarod test. The rotarod test was performed as previously 
described (Sorce et al., 2014), with minor modifications. The 
rotarod apparatus consisted of a rotating cylinder (ø 3 cm) 
subdivided into five 57-mm-wide lanes by dividers (ø 25 cm; 
Ugo Basile). Each test comprised a habituation phase and an 
experimental phase. The habituation phase consisted of three 
sessions of 1 min each, at a constant speed of 5 rotations per 
minute (rpm), with inter-session intervals of at least 15 min. 
The test phase, which started at least 15 min after the last 
habituation trial, consisted of three sessions of maximum 5 
min each, at a constant acceleration from 5 rpm to maximum 
of 40 rpm, with inter-session intervals of at least 15 min. Fall-
ing from the drum or clinging to the rod and passively rotat-
ing with it were equally considered to assess latency to fall. 
Rotarod tests were performed at the same time of the day 
(between 2 p.m. and 4 p.m.), with a 1-mo interval. In each 
cage, mice were randomly tested and the operator was 
blind to their genotype.
Histology, immunohistochemistry, and immunofluorescence. 
Hematoxylin and eosin stainings were performed on sections 
from formalin-fixed, paraffin-embedded tissue using standard 
protocols. CD68 staining was performed on 7–10 µm 
cryo-sections from snap-frozen sciatic nerves embedded in 
OCT medium as previously described (Bremer et al., 2010). 
After fixation with formalin and acetone solutions, sections 
were incubated with rat anti–mouse CD68 monoclonal anti-
body (1:100 dilution, clone FA-11; Serotec), followed by in-
cubation with goat anti–rat IgG (1:150 dilution; Antibodies 
Online), and donkey anti–goat IgG conjugated with alkaline 
phosphatase (1:80 dilution; Jackson ImmunoResearch Labo-
ratories). Immunoreactivity was visualized using the mix Fast 
Red staining kit (Sigma-Aldrich). Toluidine blue staining was 
performed using standard procedures on semi-thin sections 
(500 nm) from epon-embedded sciatic nerves that had been 
fixed in situ with 3.9% glutaraldehyde in 0.1 M PBS, pH 7.4, 
after transcardial perfusion with PBS. In all cases, slides were 
scanned with NanoZoomer and images were visualized using 
the NanoZoomer Digital Pathology System (NDPview; 
Hamamatsu Photonics). For morphometric analysis of CD68+ 
digestion chambers in sciatic nerves, at least 10 regions of 
interest per section were selected from a total of two to four 
sections per mouse. For morphometric analysis of axonal 
density in sciatic nerves, at least three regions of interest per 
section were selected from three to nine sections per mouse. 
Images were analyzed using semiautomatized softwares devel-
oped in-house. Operators were blind to the geno-
type of the analyzed cases.
Immunofluorescence stainings were performed on sec-
tions from formalin-fixed, paraffin-embedded tissue. After 
deparaffinization through graded alcohols and heat-induced 
antigen retrieval in citrate buffer (0.01 M, pH 6.0), sections 
were incubated with anti-POM19 (20 µg/ml; Polymenidou 
et al., 2008) and MAP2 (1:500; Abcam) antibodies, followed 
by incubation with fluorescently labeled secondary antibod-
ies (1:1,000; Alexa Fluor 488 or 555; Invitrogen) and with 
DAPI (Life technologies) for nuclear staining. Images were 
acquired with the fluorescence microscope (BX-61; Olym-
pus) equipped with a cooled black/white charge-coupled de-
vice camera, using identical acquisition settings.
In all cases, images were prepared using Photoshop and 
Illustrator software (Adobe).
Transmission electron microscopy. Mice under deep anes-
thesia were transcardially perfused with PBS heparin and 
sciatic nerves were then fixed in situ with 2.5% glutaralde-
hyde + 2% paraformaldehyde in 0.1 M PBS, pH 7.4. Tis-
sues were then embedded in epon, and semi-thin sections 
(500 nm) were stained with toluidine blue using standard 
procedures. Ultrathin sections were mounted on copper 
grids coated with Formvar membrane and contrasted with 
uranyl acetate/lead citrate. Specimens were examined using 
a Hitachi H-7650 electron microscope (Hitachi High-
Tech) operating at 80 kV.
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Phagocytosis assay with BM-derived macrophages (BMDMs). 
On day 1, femurs of age-matched adult males were flushed 
with culture medium (RPMI 1640, 10% FBS, 1% Glutamax 
and antibiotics; all from GE Healthcare). BM cells were and 
plated into 6-well plates (TPP) at a density of 2 × 106/well in 
3-ml culture medium enriched with 10 ng/ml of murine 
macrophage colony-stimulation factor (Invitrogen) and cul-
tured overnight at 37°C and 5% CO2. On day 2, nonadhering 
cells were transferred to a Nunc UpCell Surface cell culture 
dish (Sigma-Aldrich). On day 6, the resulting BMDMs were 
harvested, adjusted to 5 × 105 cells in 500 µl, and plated into 
24-well plates. On the same day, thymocytes were harvested 
from 6–12-wk-old C57BL/6 mice and incubated overnight 
at 37°C and 5% CO2 in culture medium in the presence of 
0.1 µM dexamethasone to induce apoptosis. On day 7, thy-
mocyte apoptosis was assessed using the FITC Annexin V 
Apoptosis Detection kit II (BD). Apoptotic thymocytes were 
washed, suspended at 106/ml in PBS, and labeled with 20 ng/
ml of the pH-sensitive dye pHrodo Red, SE (Invitrogen) for 
30 min at room temperature. Labeled thymocytes were 
washed and resuspended in culture medium to achieve differ-
ent cellular densities, and then 500 µl of cell suspension were 
added to each well of the BMDM culture for 1 h at 37°C. 
After washing, BMDMs were harvested with Stem Pro Ac-
cutase (Invitrogen) and gentle scraping, and subsequently 
stained with FITC-labeled anti-CD11b or isotype control 
antibody (BD). Flow cytometry was performed using a FAC 
SCalibur (BD) with CellQuestPro software. At least 10,000 
events were acquired in the living gate. Rate of phagocytosis 
was determined with FlowJo software (Tree Star) as the per-
centage of pHrodo positivity among CD11b+ cells.
Statistical analysis. Statistical significance was assessed using 
GraphPad Prism software with two-tailed unpaired Student’s 
t test or one- or two-way ANO VA and Bonferroni’s mul-
tiple comparison post-test, as appropriate. α level was set at 
0.05. For each statistical analysis, the statistical test, the group 
size and the resulting p-value are indicated in the corre-
sponding figure legends.
Online supplemental material. Fig. S1 shows that C57BL/6J-
PrnpZH3/ZH3 mice do not have chromosomal aberrations. 
Fig. S2 shows whole-genome SNP analysis. Fig. S3 shows 
Prnp mRNA coverage. Fig. S4 shows Sanger sequencing 
of selected genomic sites undergoing RNA editing. Fig. 
S5 shows flow cytometry analysis of phagocytic activity. 
Table S1 lists Predicted TAL EN OTs analyzed. Table S2 
lists primers and probes used. Table S3 lists DEGs between 
PrnpZH1/ZH1 and C57BL/6J hippocampi. Table S4 lists DEGs 
between PrnpZH3/ZH3 and C57BL/6J hippocampi. Table S5 
lists differentially expressed exons between PrnpZH1/ZH1 and 
C57BL/6J hippocampi. Table S6 lists loci with differential 
RNA editing level between PrnpZH1/ZH1 and C57BL/6J 
hippocampi. Table S7 lists loci with differential RNA editing 
level between PrnpZH3/ZH3 and C57BL/6J hippocampi. 
Online supplemental material is available at http ://www 
.jem .org /cgi /content /full /jem .20151610 /DC1.
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